Upgrade to SI Premium - Free Trial

Corbus Pharma (CRBP)

8.84 -0.14 (1.56%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form 8-K Corbus Pharmaceuticals For: Jul 02 July 6, 2026 8:16 AM - SEC Filing Corbus Pharmaceuticals names new chief medical officer July 6, 2026 8:01 AM - StreetInsider Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer July 6, 2026 8:00 AM - Globe NewsWire Corbus Pharmaceuticals (CRBP) PT Lowered to $34 at Mizuho June 23, 2026 9:59 AM - StreetInsider Form S-8 Corbus Pharmaceuticals June 17, 2026 4:31 PM - SEC Filing Corbus Pharmaceuticals (CRBP) PT Lowered to $52 at Oppenheimer June 17, 2026 6:03 AM - StreetInsider Corbus Pharmaceuticals (CRBP) PT Lowered to $52 at Oppenheimer June 17, 2026 6:02 AM - StreetInsider Form 4 Corbus Pharmaceuticals For: Jun 10 Filed by: Altmeyer Anne June 11, 2026 4:30 PM - SEC Filing Form 4 Corbus Pharmaceuticals For: Jun 10 Filed by: Kung Winston June 11, 2026 4:30 PM - SEC Filing Form 4 Corbus Pharmaceuticals For: Jun 10 Filed by: Jenkins John Kenneth June 11, 2026 4:30 PM - SEC Filing Form 4 Corbus Pharmaceuticals For: Jun 02 Filed by: Saxena Nishant C June 3, 2026 5:37 PM - SEC Filing Form S-8 Corbus Pharmaceuticals May 29, 2026 4:51 PM - SEC Filing Form 8-K Corbus Pharmaceuticals For: May 26 May 26, 2026 8:56 AM - SEC Filing Corbus reports CRB-701 shows 42.9% response rate in oropharyngeal cancer May 26, 2026 7:00 AM - StreetInsider Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers May 26, 2026 7:00 AM - Globe NewsWire Corbus Pharmaceuticals (CRBP) PT Raised to $44 at Mizuho May 26, 2026 6:42 AM - StreetInsider Form 4 Corbus Pharmaceuticals For: May 21 Filed by: Saxena Nishant C May 22, 2026 4:51 PM - SEC Filing Form 3 Corbus Pharmaceuticals For: May 21 Filed by: Saxena Nishant C May 22, 2026 4:50 PM - SEC Filing Corbus Pharmaceuticals (CRBP) PT Raised to $44 at Mizuho May 22, 2026 6:41 AM - StreetInsider Form 4 Corbus Pharmaceuticals For: May 19 Filed by: Kung Winston May 21, 2026 5:07 PM - SEC Filing Form 4 Corbus Pharmaceuticals For: May 19 Filed by: Jacques Rachelle Suzanne May 21, 2026 5:07 PM - SEC Filing Form 4 Corbus Pharmaceuticals For: May 19 Filed by: Jenkins John Kenneth May 21, 2026 5:06 PM - SEC Filing Form 4 Corbus Pharmaceuticals For: May 19 Filed by: Ben Yong May 21, 2026 5:06 PM - SEC Filing Form 4 Corbus Pharmaceuticals For: May 19 Filed by: Altmeyer Anne May 21, 2026 5:06 PM - SEC Filing Form 4 Corbus Pharmaceuticals For: May 19 Filed by: Pfeiffenberger Brent May 21, 2026 5:05 PM - SEC Filing Form 3 Corbus Pharmaceuticals For: May 13 Filed by: Pfeiffenberger Brent May 21, 2026 5:03 PM - SEC Filing Form 8-K Corbus Pharmaceuticals For: May 19 May 21, 2026 8:15 AM - SEC Filing Corbus names Nishant Saxena as chief business officer May 21, 2026 8:01 AM - StreetInsider Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call May 21, 2026 8:00 AM - Globe NewsWire Form SCHEDULE 13G/A Corbus Pharmaceuticals Filed by: Octagon Capital Advisors LP May 14, 2026 4:02 PM - SEC Filing Form 8-K Corbus Pharmaceuticals For: May 13 May 14, 2026 8:15 AM - SEC Filing Corbus Pharmaceuticals names Brent Pfeiffenberger to board of directors May 14, 2026 8:01 AM - StreetInsider Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors May 14, 2026 8:01 AM - Globe NewsWire Corbus Pharmaceuticals (CRBP) PT Lowered to $54 at Oppenheimer May 13, 2026 8:40 AM - StreetInsider Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences May 13, 2026 7:00 AM - Globe NewsWire Form 10-Q Corbus Pharmaceuticals For: Mar 31 May 12, 2026 4:51 PM - SEC Filing Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Jefferies May 12, 2026 4:02 PM - StreetInsider Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Jefferies May 12, 2026 4:02 PM - StreetInsider Corbus Pharma (CRBP) Misses Q1 EPS by 123c May 12, 2026 8:49 AM - StreetInsider Form 8-K Corbus Pharmaceuticals For: May 12 May 12, 2026 8:15 AM - SEC Filing Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update May 12, 2026 8:00 AM - Globe NewsWire Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026 May 5, 2026 8:00 AM - Globe NewsWire Guggenheim Starts Corbus Pharmaceuticals (CRBP) at Buy April 28, 2026 4:15 PM - StreetInsider Full Article List